University of Buea Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02832999
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

University of Buea | University of Buea, Cameroon

Active Ingredients

Drugs in Phase 4 Trials (2)

liraglutide (victoza) (1 trial)

vildagliptin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Hypersensitivity (Phase 4)

Insulin Resistance (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2